Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Salter

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Proceedings. Biological Sciences|May 22, 1991
CD8 independence and specificity of cytotoxic T lymphocytes restricted by HLA-Aw68.1V Cerundolo, A G Tse, R D Salter, et al.
The Journal of Experimental Medicine|July 1, 1987
In vitro mutagenesis at a single residue introduces B and T cell epitopes into a class I HLA moleculeR D Salter, C Clayberger, C E Lomen, et al.
Immunogenetics|January 1, 1985
Evidence for chromatin structure as a regulatory determinant in HLA-DR alpha gene expressionJ P Ting, M N Carrington, R D Salter, et al.
Nature|November 3, 1988
Cell-cell adhesion mediated by CD8 and MHC class I moleculesA M Norment, R D Salter, P Parham, et al.
Cancer Research|September 1, 1997
The biosynthesis and secretion of prostate-specific antigen in LNCaP cellsJ T Gau, R D Salter, D Krill, et al.
Human Immunology|January 8, 2000
Peptide-conformed beta2m-free class I heavy chains are intermediates in generation of soluble HLA by the membrane-bound metalloproteinaseS Demaria, L D DeVito-Haynes, R D Salter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1992
Species specificity in the interaction of CD8 with the alpha 3 domain of MHC class I moleculesM H Newberg, J P Ridge, D R Vining, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1993
Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytesW J Storkus, H J Zeh, M J Maeurer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 1999
Modification of the amino terminus of a class II epitope confers resistance to degradation by CD13 on dendritic cells and enhances presentation to T cellsX Dong, B An, L Salvucci Kierstead, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1989
HLA-B51 and HLA-Bw52 differ by only two amino acids which are in the helical region of the alpha 1 domainH Hayashi, P D Ennis, H Ariga, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Proceedings. Biological Sciences|May 22, 1991
CD8 independence and specificity of cytotoxic T lymphocytes restricted by HLA-Aw68.1V Cerundolo, A G Tse, R D Salter, et al.
The Journal of Experimental Medicine|July 1, 1987
In vitro mutagenesis at a single residue introduces B and T cell epitopes into a class I HLA moleculeR D Salter, C Clayberger, C E Lomen, et al.
Immunogenetics|January 1, 1985
Evidence for chromatin structure as a regulatory determinant in HLA-DR alpha gene expressionJ P Ting, M N Carrington, R D Salter, et al.
Nature|November 3, 1988
Cell-cell adhesion mediated by CD8 and MHC class I moleculesA M Norment, R D Salter, P Parham, et al.
Cancer Research|September 1, 1997
The biosynthesis and secretion of prostate-specific antigen in LNCaP cellsJ T Gau, R D Salter, D Krill, et al.
Human Immunology|January 8, 2000
Peptide-conformed beta2m-free class I heavy chains are intermediates in generation of soluble HLA by the membrane-bound metalloproteinaseS Demaria, L D DeVito-Haynes, R D Salter, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1992
Species specificity in the interaction of CD8 with the alpha 3 domain of MHC class I moleculesM H Newberg, J P Ridge, D R Vining, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1993
Identification of human melanoma peptides recognized by class I restricted tumor infiltrating T lymphocytesW J Storkus, H J Zeh, M J Maeurer, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 1999
Modification of the amino terminus of a class II epitope confers resistance to degradation by CD13 on dendritic cells and enhances presentation to T cellsX Dong, B An, L Salvucci Kierstead, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 1, 1989
HLA-B51 and HLA-Bw52 differ by only two amino acids which are in the helical region of the alpha 1 domainH Hayashi, P D Ennis, H Ariga, et al.
Pageof 4